Indicators
Indicators
Value
Direction
MACD(12,26,9)
1.507
Buy
RSI(14)
64.784
Neutral
STOCH(KDJ)(9,3,3)
89.481
Overbought
ATR(14)
2.185
High Vlolatility
CCI(14)
118.891
Buy
Williams %R
11.901
Overbought
TRIX(12,20)
0.300
Sell
StochRSI(14)
76.007
Sell
Search
Bruker Corp
BRKRAdd to Watchlist
44.730USD
+1.460+3.37%
Close 05/12, 16:00（ET）Quotes delayed by 15 min
6.81BMarket Cap
LossP/E TTM
TradingKey Stock Score
Overall Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Peer Comparison
TradingKey Stock Score of Bruker Corp
Currency: USD Updated: 2026-05-11Key Insights
Bruker Corp's fundamentals are relatively stable, with an industry-leading ESG disclosure.and its growth potential is high.Its valuation is considered fairly valued, ranking 5 out of 206 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 48.11.In the medium term, the stock price is expected to trend up.The company has been performing well in the stock market over the past month, which is supported by its strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Bruker Corp's Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Media Coverage
Last 24 hours
Coverage Level
Very Low
Very High
Negative
Bruker Corp Highlights
StrengthsRisks
Bruker Corporation is a developer, manufacturer and distributor of high-performance scientific instruments and analytical and diagnostic. Its segments include Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI NANO, and Bruker Energy & Supercon Technologies (BEST). BSI segment designs, manufactures and distributes life science tools based on magnetic resonance technology and offers automated laboratory research. BSI CALID segment designs, manufactures and distributes life science mass spectrometry, applied spectrometry and ion mobility spectrometry solutions, analytical and process analysis instruments and solutions. BSI NANO designs, manufactures and distributes advanced x-ray instruments, atomic force microscopy instrumentation, and fluorescence optical microscopy instruments. BEST segment develops and manufactures superconducting and non-superconducting materials and devices for use in renewable energy, energy infrastructure, healthcare and energy physics research.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 15.92% year-on-year.
Turnaround to Loss
The company's performance has turned to a loss, with the latest annual loss of USD .
High Dividend
The company is a high dividend payer, with the latest dividend payout ratio of 26.70%.
Stable Dividend
The company has regularly paid dividends over the past 5 years, with the latest dividend payout ratio of 26.70%.
Undervalued
The company’s latest PE is -180.29, at a low 3-year percentile range.
Institutional Selling
The latest institutional holdings are 139.65M shares, decreasing 9.59% quarter-over-quarter.
Held by ETHSX
Star Investor ETHSX holds 3.77K shares of this stock.
Analyst Rating
Based on
16
analysts
Buy
Current Rating
48.111
Target Price
+8.95%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
Financial Health
Currency: USD Updated: 2026-05-11The current financial score of Bruker Corp is 8.43, ranking 33 out of 206 in the Healthcare Equipment & Supplies industry. Its financial status is weak, and its operating efficiency is high. Its latest quarterly revenue reached 823.40M, representing a year-over-year increase of 2.75%, while its net profit experienced a year-over-year increase of 79.89%.
Score
Financials
5.12
Key Metrics
Cash and cash equivalents
Total assets
Total liabilities
Free cash flow
Relevant data have not been disclosed by the company yet.
Quality of Earnings
10.00
Operational Efficiency
8.60
Growth Potential
9.00
Shareholder Returns
9.45
Bruker Corp's Company Valuation
Currency: USD Updated: 2026-05-11The current valuation score of Bruker Corp is 6.80, ranking 144 out of 206 in the Healthcare Equipment & Supplies industry. Its current P/E ratio is -180.29, which is -146.49% below the recent high of 83.82 and -90.40% above the recent low of -343.27.
Score
Valuation Dimensions
P/E
P/B
P/S
P/CF
Industry Ranking 5/206
Relevant data have not been disclosed by the company yet.
Earnings Forecast
Currency: USD Updated: 2026-05-11The current earnings forecast score of Bruker Corp is 7.63, ranking 128 out of 206 in the Healthcare Equipment & Supplies industry. The average price target is 43.00, with a high of 75.00 and a low of 36.00.
Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Analyst Rating
Based on
16
analysts
Buy
Current Rating
47.777
Target Price
+8.19%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
93
Total
4
Median
7
Average
Company name
Ratings
Analysts
Bruker Corp
BRKR
16
Boston Scientific Corp
BSX
37
Intuitive Surgical Inc
ISRG
35
Edwards Lifesciences Corp
EW
34
Veeva Systems Inc
VEEV
33
Thermo Fisher Scientific Inc
TMO
31
1
2
3
...
19
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Relevant data have not been disclosed by the company yet.
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
Price Momentum
Currency: USD Updated: 2026-05-11The current price momentum score of Bruker Corp is 9.40, ranking 9 out of 206 in the Healthcare Equipment & Supplies industry. Currently, the stock price is trading between the resistance level at 47.28 and the support level at 36.53, making it suitable for range-bound swing trading.
Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Indicators
The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.
This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.
Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.
Moving Average
Indicators
Value
Direction
MA5
42.294
Buy
MA10
39.191
Buy
MA20
39.055
Buy
MA50
37.317
Buy
MA100
41.484
Buy
MA200
39.566
Buy
Institutional Confidence
Currency: USD Updated: 2026-05-11The current institutional shareholding score of Bruker Corp is 10.00, ranking 1 out of 206 in the Healthcare Equipment & Supplies industry. The latest institutional shareholding proportion is 91.74%, representing a quarter-over-quarter decrease of 2.53%. The largest institutional shareholder is PRFDX, holding a total of 2.28M shares, representing 1.50% of shares outstanding, with 99640.00% increase in holdings.
Score
Institutional Shareholding
Relevant data have not been disclosed by the company yet.
Risk Assessment
Currency: USD Updated: 2026-05-11The U.S. Dollar Index is currently in a neutral state, which has a neutral effect on the Healthcare Equipment & Supplies domestic-focused industry. The Dollar Index (DXY) measures the value of the U.S. dollar against a basket of major currencies, including the euro, yen, pound sterling, Canadian dollar, Swedish krona, and Swiss franc. The current risk assessment score of Bruker Corp is 7.43, ranking 40 out of 206 in the Healthcare Equipment & Supplies industry. The company's beta value is 1.15. This indicates that the stock tends to outperform the index during upward trending markets but experiences larger declines during downward trending markets. Bruker Corp’s latest ESG disclosure leads the Healthcare Equipment & Supplies industry, indicating outstanding, compliant performance across environmental management, social responsibility, and governance, which may help mitigate overall risk.
Score
Beta vs S&P 500 index
1.14
VaR
+3.99%
240-Day Maximum Drawdown
+39.85%
240-Day Volatility
+55.54%
Return
Best Daily Return
60 days
+11.29%
120 days
+11.29%
5 years
+13.28%
Worst Daily Return
60 days
-11.60%
120 days
-11.60%
5 years
-12.12%
Sharpe Ratio
60 days
+0.42
120 days
+0.39
5 years
-0.11
Risk Assessment
Maximum Drawdown
240 days
+39.85%
3 years
+68.87%
5 years
+68.87%
Return-to-Drawdown Ratio
240 days
+0.41
3 years
-0.20
5 years
-0.14
Skewness
240 days
-0.31
3 years
-0.04
5 years
-0.01
Volatility
Realised Volatility
240 days
+55.54%
5 years
+43.70%
Standardised True Range
240 days
+4.29%
5 years
+4.97%
Downside Risk-Adjusted Return
120 days
+61.37%
240 days
+61.37%
Maximum Daily Upside Volatility
60 days
+42.09%
Maximum Daily Downside Volatility
60 days
+40.81%
Liquidity
Average Turnover Rate
60 days
+1.47%
120 days
+1.48%
5 years
--
Turnover Deviation
20 days
-5.43%
60 days
+0.95%
120 days
+1.76%
Peer Comparison
Healthcare Equipment & Supplies
Bruker Corp
BRKR
8.28 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Lantheus Holdings Inc
LNTH
8.72 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Anika Therapeutics Inc
ANIK
8.53 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
LivaNova PLC
LIVN
8.38 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
West Pharmaceutical Services Inc
WST
8.36 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Thermo Fisher Scientific Inc
TMO
8.36 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
View more
